These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27712589)

  • 1. Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer Cells.
    Isono M; Sato A; Okubo K; Asano T; Asano T
    Oncol Res; 2016; 24(5):327-335. PubMed ID: 27712589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Panobinostat synergizes with bortezomib to induce endoplasmic reticulum stress and ubiquitinated protein accumulation in renal cancer cells.
    Sato A; Asano T; Isono M; Ito K; Asano T
    BMC Urol; 2014 Aug; 14():71. PubMed ID: 25176354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer Cells.
    Isono M; Sato A; Asano T; Okubo K; Asano T
    Anticancer Res; 2018 Jun; 38(6):3493-3500. PubMed ID: 29848702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Dual Histone Deacetylase-Proteasome Inhibitor RTS-V5 Acts Synergistically With Ritonavir to Induce Endoplasmic Reticulum Stress in Bladder Cancer Cells.
    Okubo K; REßING N; Schulz WA; Hansen FK; Asano T; Sato A
    Anticancer Res; 2021 Dec; 41(12):5987-5996. PubMed ID: 34848452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment of renal cell carcinoma with belinostat and 5-fluorouracil: a role for oxidative stress induced DNA damage and HSP90 regulated thymidine synthase.
    Kim MJ; Lee JS; Park SE; Yi HJ; Jeong IG; Kang JS; Yun J; Lee JY; Ro S; Lee JS; Choi EK; Hwang JJ; Kim CS
    J Urol; 2015 May; 193(5):1660-8. PubMed ID: 25433307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ritonavir interacts with bortezomib to enhance protein ubiquitination and histone acetylation synergistically in renal cancer cells.
    Sato A; Asano T; Ito K; Asano T
    Urology; 2012 Apr; 79(4):966.e13-21. PubMed ID: 22296623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelfinavir and Ritonavir Kill Bladder Cancer Cells Synergistically by Inducing Endoplasmic Reticulum Stress.
    Sato A; Asano T; Okubo K; Isono M; Asano T
    Oncol Res; 2018 Mar; 26(2):323-332. PubMed ID: 28560953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells.
    Okubo K; Isono M; Miyai K; Asano T; Sato A
    Cancer Sci; 2020 Jan; 111(1):112-126. PubMed ID: 31675763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum Stress.
    Okubo K; Isono M; Asano T; Sato A
    Anticancer Res; 2018 Oct; 38(10):5615-5626. PubMed ID: 30275179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.
    Sato A; Asano T; Okubo K; Isono M; Asano T
    Cancer Sci; 2017 Jun; 108(6):1194-1202. PubMed ID: 28342223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental in vivo and in vitro treatment with a new histone deacetylase inhibitor belinostat inhibits the growth of pancreatic cancer.
    Dovzhanskiy DI; Arnold SM; Hackert T; Oehme I; Witt O; Felix K; Giese N; Werner J
    BMC Cancer; 2012 Jun; 12():226. PubMed ID: 22681698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells.
    Savickiene J; Treigyte G; Valiuliene G; Stirblyte I; Navakauskiene R
    Anticancer Drugs; 2014 Sep; 25(8):938-49. PubMed ID: 24800886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suberoylanilide hydroxamic acid (SAHA) combined with bortezomib inhibits renal cancer growth by enhancing histone acetylation and protein ubiquitination synergistically.
    Sato A; Asano T; Ito K; Sumitomo M; Asano T
    BJU Int; 2012 Apr; 109(8):1258-68. PubMed ID: 21895936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.
    Touma SE; Goldberg JS; Moench P; Guo X; Tickoo SK; Gudas LJ; Nanus DM
    Clin Cancer Res; 2005 May; 11(9):3558-66. PubMed ID: 15867260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of suberoylanilide hydroxamic acid and ritonavir is effective against renal cancer cells.
    Sato A; Asano T; Horiguchi A; Ito K; Sumitomo M; Asano T
    Urology; 2010 Sep; 76(3):764.e7-13. PubMed ID: 20630573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of suberoylanilide hydroxamic acid and topotecan in renal cancer cells.
    Sato A; Asano T; Horiguchi A; Ito K; Sumitomo M; Asano T
    Oncol Res; 2011; 19(5):217-23. PubMed ID: 21542457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells.
    Rao R; Balusu R; Fiskus W; Mudunuru U; Venkannagari S; Chauhan L; Smith JE; Hembruff SL; Ha K; Atadja P; Bhalla KN
    Mol Cancer Ther; 2012 Apr; 11(4):973-83. PubMed ID: 22367781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
    Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
    Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17-Allylamino-17-demethoxygeldanamycin and ritonavir inhibit renal cancer growth by inhibiting the expression of heat shock factor-1.
    Sato A; Asano T; Ito K; Asano T
    Int J Oncol; 2012 Jul; 41(1):46-52. PubMed ID: 22470109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone Deacetylase Inhibitors Dose-Dependently Switch Neutrophil Death from NETosis to Apoptosis.
    Hamam HJ; Palaniyar N
    Biomolecules; 2019 May; 9(5):. PubMed ID: 31083537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.